Growth Metrics

AVITA Medical (RCEL) Return on Equity (2019 - 2025)

AVITA Medical filings provide 7 years of Return on Equity readings, the most recent being 0.04% for Q4 2025.

  • On a quarterly basis, Return on Equity rose 12.0% to 0.04% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.04%, a 12.0% increase, with the full-year FY2025 number at 0.08%, up 10.0% from a year prior.
  • Return on Equity hit 0.04% in Q4 2025 for AVITA Medical, down from 0.05% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 15.84% in Q1 2025 to a low of 0.07% in Q4 2024.
  • Median Return on Equity over the past 5 years was 0.0% (2021), compared with a mean of 0.79%.
  • Biggest five-year swings in Return on Equity: decreased -8bps in 2024 and later soared 1584bps in 2025.
  • AVITA Medical's Return on Equity stood at 0.0% in 2021, then plummeted by -54bps to 0.0% in 2022, then skyrocketed by 170bps to 0.0% in 2023, then crashed by -4549bps to 0.07% in 2024, then surged by 156bps to 0.04% in 2025.
  • The last three reported values for Return on Equity were 0.04% (Q4 2025), 0.05% (Q3 2025), and 0.06% (Q2 2025) per Business Quant data.